Design and synthesis of quipazine based Re-complexes for the development of potential SPECT imaging agents with 99mTc for 5-HT transporter

Bulletin of the Korean Chemical Society

Volumn 23, Issue 10, 2002, Pages 1439-1444

  In, Mi Young ^a   Chi, Dae Yoon ^b   Choi, Sun Ju ^c   Park, Kyung Bae ^c   Cho, Cheon Gyu ^a  

^a Hanyang University   (South Korea)

^b Inha University   (South Korea)

^c Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Radiotracer; Rhenium; Serotonin; SPECT; Technetium

Indexed keywords

QUIPAZINE; RHENIUM COMPLEX; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TECHNETIUM 99M; TRACER;

ARTICLE; BINDING AFFINITY; CHELATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0037145545     PISSN: 02532964     EISSN: None     Source Type: Journal    
DOI: 10.5012/bkcs.2002.23.10.1439     Document Type: Article

References (20)

1. Povlock, S. L.; Amara, S. G. In Neurotransmitter Transporters; Structure, Function and Regulation; Reith, M. E. A., Ed.; Humania: New Jersey, 1997; pp 1-28.
2. Meltzer, C. C.; Smith, G.; Dekosky, S. T.; Pollock, B. G.; Mathis, C. A.; Moore, R. Y.; Kupfer, J. J.; Reynolds, C. F. Neuropsycopharmacology 1998, 18, 407.
3. (a) Frazer, A. J. Clin. Psychiatry 1997, 6, 9.
4. (b) Wong, D. T.; Bymaster, F. P. Adv. Exp. Med. Biol. 1995, 363, 77.
5. (b) Szabo, Z.; Scheffel, U.; Mathews, W. B.; Ravert, H. T.; Szabo, K.; Kraut, M.; Palmon, S.; Ricaurte, G. A.; Dannals, R. F. J. Cereb. Blood Flow Metab. 1999, 19, 967.
6. (c) Wilson, A. A.; Ginovart, N.; Schmidt, M.; Meyer, J. H.; Threlkeld, P. G.; Houle, S. J. Med. Chem. 2000, 43, 3103.
7. Suehiro, M.; Scheffel, U.; Ravert, H. T.; Dannals, R. F.; Wagner, H. N., Jr. Life Sci. 1993, 53, 883.
8. Oya, S.; Kung, M.-P.; Acton, P. D.; Mu, M.; Hou, C.; Kung, H. F. J. Med. Chem. 1999, 42, 333.
9. (a) Hashimoto, K.; Goromaru, T. Eur. J. Pharmacol. 1990, 180, 272.
10. (b) Hashimoto, K.; Goromaru, T. Neuropharmacology 1991, 30, 113.
11. Volkert, W. A.; Jurisson, S. In Technetium and Rhenium: Their Chemistry and Its Applications; Yoshihara, K.; Omori, T., Ed.; Springer: New York, 1993; p 123.
12. (a) Mathis, C. A.; Enas, J. D.; Hanrahan, S. M.; Akgun, E. J. Labelled Compd. Radiopharm. 1994, 34, 905.
13. (b) Mathis, C. A.; Taylor, S. E.; Biegon, A.; Enas, J. D. Brain Research 1993, 619, 229.
14. (c) Biegon, A.; Mathis, C. A.; Hanrahan, S. M.; Jagust, W. J. Brain Research 1993, 619, 236.
15. (a) Jagust, W. J.; Eberling, J. L.; Biegon, A.; Taylor, S. E.; VanBrocklin, H. F.; Jordan, S.; Hanrahan, S. M.; Roberts, J. A.; Brennan, K. M.; Mathis, C. A. J. Nucl. Med. 1996, 37, 1207-1214.
16. (b) Lundkvist, C.; Loc'h, C.; Halldin, C.; Mathis, C.; Swahn, C.G.; Mertens, J.; Farde, L.; Maziere, B. J. Labelled Compd. Radiopharm. 1997, 40, 586.
17. (a) Lee, B. S.; Chu, S.; Chi, D. Y.; Choe, Y. S.; Jeong, K. J.; Jin, C. J. Med. Chem. 2002, submitted.
18. (b) Lee, B. S.; Chu, S.; Lee, B. C.; Chi, D. Y.; Choe, Y. S.; Jeong, K. J.; Jin, C. Bioorg. Med. Chem. Lett. 2000, 10, 1559.
19. (c) Lee, B. S.; Lee, B. C.; Jun, J.-G.; Chi, D. Y. Heterocycles 1998, 48, 2637.
20. O'Neil, J. P.; Wilson, S. R.; Katzenellenbogen, J. A. Inorg. Chem. 1994, 33, 319.